Published in J Clin Pathol on September 01, 1995
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer (1983) 11.19
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood (1993) 2.98
The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol (1988) 2.05
Smoldering multiple myeloma. N Engl J Med (1980) 1.77
Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood (1988) 1.55
Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North Am (1992) 1.55
Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma. Blood (1988) 1.21
Staging and kinetics of multiple myeloma. Semin Oncol (1986) 1.19
Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy. Br J Haematol (1984) 1.12
Clinical classification of plasma cell myeloma. Arch Intern Med (1975) 1.08
Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease. Clin Exp Immunol (1984) 0.95
Monoclonal gammopathies of undetermined significance. Semin Hematol (1989) 0.92
Increased expression of natural-killer-associated and activation antigens in multiple myeloma. Am J Hematol (1992) 0.91
Prognostic significance of plasma cell morphology in multiple myeloma. Cancer (1987) 0.90
Analysis of multidrug-resistance (MDR-1) glycoprotein and CD56 expression to separate monoclonal gammopathy from multiple myeloma. Br J Haematol (1993) 0.87
Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67. Br J Haematol (1988) 0.86
Prognostic factors and classification in multiple myeloma. Br J Cancer (1989) 0.83
Characterisation of normal peripheral blood cells in cycle identified by monoclonal antibody Ki-67. J Clin Pathol (1992) 0.82
Lymphoid subsets and prognostic factors in multiple myeloma. Cooperative Group for the Study of Monoclonal Gammopathies. Br J Haematol (1992) 0.82
Biology of multiple myeloma--host-tumour interactions and immune regulation of disease activity. Hematol Oncol (1988) 0.80
Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity. Leukemia (1992) 0.80
Multiple myeloma: relationship between survival and cellular morphology. Am J Hematol (1990) 0.80
New treatment strategies for multiple myeloma. Am J Hematol (1990) 0.79
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol (1976) 13.98
Proposals for the classification of the myelodysplastic syndromes. Br J Haematol (1982) 10.90
Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 6.82
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet (2007) 6.29
Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia (1995) 4.04
Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet (1982) 3.67
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer (1982) 2.71
A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol (1992) 2.33
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol (1991) 2.23
Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 2.22
Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol (1998) 2.21
The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol (1994) 2.20
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol (1989) 2.13
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia (1994) 2.11
Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type. Am J Surg Pathol (1995) 2.09
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood (1998) 1.95
Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood (1991) 1.79
HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response. AIDS Res Hum Retroviruses (1988) 1.74
Mouse red-cell rosettes in B-lymphoproliferative disorders. Br J Haematol (1976) 1.72
Prolymphocytic leukaemia. Br J Haematol (1974) 1.66
The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol (1981) 1.64
The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients. Br J Haematol (1980) 1.63
Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases. J Clin Pathol (1989) 1.62
A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res (1985) 1.61
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol (1997) 1.59
The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome. Leuk Res (2011) 1.58
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia. J Clin Oncol (1997) 1.57
Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol (1997) 1.54
B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. Blood (1990) 1.53
The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders. Am J Pathol (1991) 1.53
The morphological spectrum of T-prolymphocytic leukaemia. Br J Haematol (1986) 1.52
1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk Res (1983) 1.48
Co-trimoxazole for prevention of infection in acute leukaemia. Lancet (1978) 1.47
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol (1997) 1.47
Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. Lancet (1990) 1.47
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol (1986) 1.47
T-lymphocyte colonies in normal blood, bone marrow and lymphoproliferative disorders. Clin Exp Immunol (1979) 1.46
Isochromosome 17q in Ph1-negative leukemia: a clinical, cytogenetic, and molecular study. Blood (1990) 1.46
Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clin Lab Haematol (2002) 1.46
Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood (1998) 1.46
Outcome of biphenotypic acute leukemia. Haematologica (1999) 1.46
Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med (1978) 1.46
Chronic myelomonocytic leukaemia. Br J Haematol (1975) 1.45
Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity. J Clin Oncol (1995) 1.43
The distribution of CD45R, CD29 and CD45RO (UCHL1) antigens in mature CD4 positive T-cell leukaemias. Br J Haematol (1990) 1.41
Central nervous system involvement demonstrated by immunological study in prolymphocytic variant of chronic lymphocytic leukemia. Acta Haematol (1989) 1.41
Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood (1997) 1.41
Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. J Clin Pathol (1987) 1.40
Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet (1984) 1.38
Definition of acute biphenotypic leukemia. Haematologica (1997) 1.37
The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp Hematol (1989) 1.35
Multiparameter studies in lymphoid leukemias. Am J Clin Pathol (1979) 1.34
Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet (1997) 1.32
Phenotypic heterogeneity and cellular origins of T cell malignancies. Leuk Res (1981) 1.32
Hairy-cell leukaemia and prolymphocytic leukaemia. Clin Haematol (1977) 1.31
Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia. J Hosp Infect (1984) 1.31
The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol (1994) 1.30
Terminal deoxynucleotidyl-transferase levels and membrane phenotypes in diagnosis of acute leukaemia. Lancet (1977) 1.30
The variant form of hairy-cell leukaemia. Best Pract Res Clin Haematol (2003) 1.29
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood (2001) 1.27
The B-lymphocyte nature of the hairy cell of leukaemic reticuloendotheliosis. Br J Haematol (1974) 1.27
Clinical significance of T-cells in chronic lymphocytic leukaemia. Lancet (1974) 1.26
Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res (1983) 1.25
Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H. Leuk Res (1998) 1.25
Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia. Free Radic Biol Med (2001) 1.25
Guidelines on the diagnosis and management of chronic lymphocytic leukaemia. Br J Haematol (2004) 1.24
Thromboembolic complications in myelomatosis. Br Med J (1970) 1.23
Prolymphocytic leukaemia of B and T cell type. Lancet (1973) 1.23
Blast crisis of chronic myeloid leukaemia (CML). II. Cell surface marker analysis of "lymphoid" and myeloid cases. Br J Haematol (1976) 1.22
Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia. J Clin Pathol (1974) 1.22
The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood (1994) 1.19
Increase of T lymphocytes in the spleen in Hodgkin's disease. Lancet (1974) 1.18
Hypokalaemia and raised lysozyme levels in acute myeloid leukaemia. Q J Med (1973) 1.18
Cytogenetic findings in acute biphenotypic leukaemia. Leukemia (1996) 1.16
A classification of acute leukaemia for the 1990s. Ann Hematol (1991) 1.15
Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia. Br J Haematol (1981) 1.15
Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia. Br J Haematol (1997) 1.14
bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. Blood (1986) 1.14
Leukaemic reticuloendotheliosis ('Hairy' cell leukaemia): a distinct clinico-pathological entity. Br J Haematol (1974) 1.14
Cutaneous findings in chronic lymphocytic leukaemia. Br J Dermatol (2004) 1.14
Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. J Clin Oncol (1997) 1.13